GVS SpA
MIL:GVS
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
4.825
7.29
|
Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
GVS SpA
Cash & Cash Equivalents
GVS SpA
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
GVS SpA
MIL:GVS
|
Cash & Cash Equivalents
€191.5m
|
CAGR 3-Years
15%
|
CAGR 5-Years
33%
|
CAGR 10-Years
N/A
|
||
D
|
Danieli & C Officine Meccaniche SpA
MIL:DAN
|
Cash & Cash Equivalents
€2.1B
|
CAGR 3-Years
26%
|
CAGR 5-Years
14%
|
CAGR 10-Years
5%
|
|
Interpump Group SpA
MIL:IP
|
Cash & Cash Equivalents
€378.6m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
21%
|
CAGR 10-Years
15%
|
||
Piovan SpA
MIL:PVN
|
Cash & Cash Equivalents
€74.5m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
||
I
|
Industrie De Nora SpA
MIL:DNR
|
Cash & Cash Equivalents
€198.5m
|
CAGR 3-Years
38%
|
CAGR 5-Years
36%
|
CAGR 10-Years
N/A
|
|
Antares Vision SpA
MIL:AV
|
Cash & Cash Equivalents
€47.5m
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
N/A
|
GVS SpA
Glance View
GVS SpA engages in the manufacture of filter solutions for the healthcare and life sciences, energy and mobility, and health and safety industry application sectors. The company is headquartered in Zola Predosa, Bologna and currently employs 3,077 full-time employees. The company went IPO on 2020-06-19. Its offering includes seven product lines: Healthcare, Laboratory, Mobility, Air Safety, Appliance, Personal Safety and Membranes. Each product line provides a suite of customizable solutions specifically related to each market. Additionally, the Company offers tailormade product and process development services, which cover all the project stages, including product and process design, validation, up to the mass production for large quantities. The company is active globally.
See Also
What is GVS SpA's Cash & Cash Equivalents?
Cash & Cash Equivalents
191.5m
EUR
Based on the financial report for Dec 31, 2023, GVS SpA's Cash & Cash Equivalents amounts to 191.5m EUR.
What is GVS SpA's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
33%
Over the last year, the Cash & Cash Equivalents growth was 42%. The average annual Cash & Cash Equivalents growth rates for GVS SpA have been 15% over the past three years , 33% over the past five years .